CBX3

Chromobox protein homolog 3 · Q13185 · CBX3 on Sugi Atlas →

0 patent compounds predicted against CBX3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CBX3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure PHASE2COMPLETED
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer PHASE1/PHASE2SUSPENDED
Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer PHASE1/PHASE2WITHDRAWN
Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) PHASE2ACTIVE_NOT_RECRUITING
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer PHASE2UNKNOWN
Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis PHASE1/PHASE2RECRUITING
Phase II Study of Vandetanib in Individuals With Kidney Cancer PHASE2COMPLETED
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma PHASE1/PHASE2COMPLETED
Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma PHASE2ACTIVE_NOT_RECRUITING
Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency PHASE1RECRUITING
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes nanACTIVE_NOT_RECRUITING
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants nanRECRUITING
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease nanUNKNOWN
The Danish TURNER Cryopreservation Study nanRECRUITING
Chordoma Family Study nanCOMPLETED
Familial Investigations of Childhood Cancer Predisposition nanRECRUITING
Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells. nanUNKNOWN
Cause of Familial Testicular Cancer nanCOMPLETED
Epithelioid Haemangioendothelioma Observational Study nanRECRUITING
Characterization of At-risk Population for Pre-sacral Tumor in CURRARINO Syndrome nanCOMPLETED
Prospective Study of Molecular Predictors of Survival in Myelodysplastic Syndromes nanCOMPLETED
Study of the Sex Differences in Inflammatory Diseases in Children nanUNKNOWN
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Study of Tazemetostat in Adults With Follicular Lymphoma Previously Treated With at Least Two Therapies nanWITHDRAWN

Related proteins — ESM-2 sequence neighbours (a CBX3 binder may also engage these)

ProteinNameSimilarity
Q5R6X7 1.000 Q5R6X7 →
P23198 1.000 P23198 →
P83916 0.999 P83916 →
P83917 0.997 P83917 →
Q61686 0.996 Q61686 →
P45973 0.993 P45973 →
P05205 0.991 P05205 →
P29227 0.982 P29227 →
Q8RXT5 0.978 Q8RXT5 →
B6ZLK2 0.977 B6ZLK2 →
Q29NG1 0.977 Q29NG1 →
J9VQZ0 0.977 J9VQZ0 →
G5EDE2 0.976 G5EDE2 →
D3ZA12 0.976 D3ZA12 →
G5EET5 0.976 G5EET5 →
Q8RWV8 0.976 Q8RWV8 →
Q8R5C8 0.976 Q8R5C8 →
Q94C32 0.976 Q94C32 →
E9PZM4 0.976 E9PZM4 →
A3KFM7 0.976 A3KFM7 →
Q1JQD9 0.976 Q1JQD9 →
Q15326 0.976 Q15326 →
I1HNB2 0.975 I1HNB2 →
SMARCC2 SWI/SNF complex subunit SMARCC2 0.975 landscape →
Q8TD26 0.975 Q8TD26 →
Q5SMU7 0.974 Q5SMU7 →
P60889 0.974 P60889 →
Q8T079 0.974 Q8T079 →
RCOR1 REST corepressor 1 (Protein CoREST) 0.974 landscape →
Q7ZTQ5 0.974 Q7ZTQ5 →